The neoductgenesis group was also characterized by larger tumor sizes (27.37 ± 18.31 mm vs. 12.30 ± 11.06 mm, pBH < 0.001) and lower ER (33.7 ± 39.6% vs. 64.1 ± 37.1%, pBH = 0.021) and PR (19.2 ± 33.5% vs. 38.2 ± 37.0%, pBH = 0.028) expressions. The gene discussed is PGR; the disease is neoplasm.